EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SPARC Promotes the Proliferation and Migration of Endometriotic Stromal Cells via the PI3K/AKT and MAPK/ERK Signaling Pathways

Xiaoqing Li, Zunpeng Wang, Yan He, Shuo Wang, Peng Liu, Jianfeng Wu, Shan Yu

Clinical and Experimental Obstetrics & Gynecology · 19.08.2026 · 53 (8)

DOI: 10.31083/ceog48963 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Obstetrics & Gynecology, online erschienen am 19.08.2026. Verfasst von Xiaoqing Li und 6 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Project of China Primary Health Care Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background:Endometriosis is a major contributor to infertility, and an effective curative treatment remains unavailable. SPARC has been identified as a differentially expressed gene in endometriosis between peritoneal and ovarian lesions. In this study, our aim was to comprehensively evaluate the effects of SPARC on the proliferation, migration, apoptosis, necrosis, and adhesion of endometriotic stromal cells (ESCs) in vitro and to explore the associated molecular signaling pathways.Methods:Using ESCs transfected with si-SPARC for gene silencing and those with SPARC overexpression; we evaluated cell proliferation through the Cell Counting Kit-8 (CCK-8) assay. Migratory capacity was examined using the wound-healing and Transwell assays. Cell apoptosis, necrosis, and adhesion capabilities were evaluated using the corresponding experimental methods. Immunohistochemistry was utilized to confirm SPARC expression in endometriotic lesions, and Western blot was conducted to assess protein expression.Results:The CCK‑8 assay demonstrated that si‑SPARC inhibited ESCs proliferation, whereas SPARC overexpression promoted it. Transwell and wound-healing assays showed that si‑SPARC attenuated the migration ability of ESCs, whereas SPARC overexpression was associated with enhanced cell migration. Based on qualitative Hoechst/propidium iodide (PI) staining, SPARC did not show a significant effect on apoptosis or necrosis. Moreover, the study did not conclusively establish that SPARC regulates ESC adhesion to extracellular matrix (ECM) components, such as collagen I, fibronectin, poly‑L‑lysine, and laminin. Immunohistochemistry results further showed that SPARC expression was higher in ectopic endometrium compared with orthotopic endometrium. Finally, we observed that SPARC was involved in the regulation of the mitogen-activated protein kinases/extracellular regulated protein kinases (MAPK/ERK) and phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signaling pathways.Conclusions:Our in vitro findings suggest that SPARC may promote ESC proliferation and migration, potentially via activation of the MAPK/ERK and PI3K/AKT signaling pathways. Qualitative Hoechst/PI staining showed no apparent effect of SPARC on apoptosis or necrosis, although subtle effects cannot be excluded. The effects of SPARC on ESCs' adhesion to the ECM were inconsistent, possibly reflecting differences between cell models.

Förderung

  • Research Project of China Primary Health Care Foundation

Zitieren

APA

Li, X., Wang, Z., He, Y., Wang, S., Liu, P., Wu, J., & Yu, S. (2026). SPARC Promotes the Proliferation and Migration of Endometriotic Stromal Cells via the PI3K/AKT and MAPK/ERK Signaling Pathways. Clinical and Experimental Obstetrics & Gynecology, 53(8). https://doi.org/10.31083/ceog48963

Vancouver

Li X, Wang Z, He Y, Wang S, Liu P, Wu J, et al. SPARC Promotes the Proliferation and Migration of Endometriotic Stromal Cells via the PI3K/AKT and MAPK/ERK Signaling Pathways. Clinical and Experimental Obstetrics & Gynecology. 2026;53(8). doi:10.31083/ceog48963

BibTeX
@article{Li2026,
  author = {Li, Xiaoqing and Wang, Zunpeng and He, Yan and Wang, Shuo and Liu, Peng and Wu, Jianfeng and Yu, Shan},
  title = {SPARC Promotes the Proliferation and Migration of Endometriotic Stromal Cells via the PI3K/AKT and MAPK/ERK Signaling Pathways},
  journal = {Clinical and Experimental Obstetrics & Gynecology},
  year = {2026},
  volume = {53},
  number = {8},
  doi = {10.31083/ceog48963}
}
Kostenlos starten →